Heidelberg Pharma

Provider of preclinical services specializing in ADCs (Antibody Drug Conjugates)

placeFrankfurt Am Main, Hesse, Germany calendar_todayFounded 1999 groups113 employees language heidelberg-pharma.com

Registered entities

Innovation

17 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 418 times.

YearFilings
20132
20144
20154
20166
20176
20186
20196
20203
20214
20223
20231
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon